- Home
- Publications
- Publication Search
- Publication Details
Title
TIM-3 in Leukemia; Immune Response and Beyond
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-30
DOI
10.3389/fonc.2021.753677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors
- (2021) Matthew D. Hellmann et al. CLINICAL CANCER RESEARCH
- Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody
- (2021) James J. Harding et al. CLINICAL CANCER RESEARCH
- One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia
- (2021) Zhiding Wang et al. Frontiers in Immunology
- Increasing Tim‐3+CD244+, Tim‐3+CD57+, and Tim‐3+PD‐1+ T cells in patients with acute myeloid leukemia
- (2020) Jiaxiong Tan et al. Asia-Pacific Journal of Clinical Oncology
- Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
- (2020) Uma Borate et al. BLOOD
- The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
- (2020) Alexandra Schnell et al. CELL RESEARCH
- European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
- (2020) A. Hochhaus et al. LEUKEMIA
- Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients
- (2020) Franziska Blaeschke et al. LEUKEMIA
- Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8+ T cells in early clinical stages of chronic lymphocytic leukemia
- (2020) Hadiseh Rezazadeh et al. IMMUNOLOGIC RESEARCH
- TIM-3 pathway dysregulation and targeting in cancer
- (2020) Amer M Zeidan et al. Expert Review of Anticancer Therapy
- The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
- (2020) Mazdak Ganjalikhani Hakemi et al. Frontiers in Oncology
- Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia
- (2019) Leila Hadadi et al. Oncology Research and Treatment
- Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy
- (2019) Paola Dama et al. Journal for ImmunoTherapy of Cancer
- Elevated TIM3 expression of T helper cells affects immune system in patients with myelodysplastic syndrome
- (2019) Rong Fu et al. JOURNAL OF INVESTIGATIVE MEDICINE
- CD8 + T cells exhaustion induced by myeloid‐derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal‐9 pathway
- (2019) Jinglian Tao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma
- (2018) Furong Liu et al. BULLETIN DU CANCER
- Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia
- (2018) Asmaa M. Zahran et al. Cancer Biomarkers
- T cell exhaustion characterized by compromised MHC class I and II restricted cytotoxic activity associates with acute B lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
- (2018) Long Liu et al. CLINICAL IMMUNOLOGY
- Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
- (2018) Susanne Saussele et al. LANCET ONCOLOGY
- Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
- (2018) Oscar Brück et al. LEUKEMIA
- Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it
- (2018) Amer M. Zeidan et al. BLOOD REVIEWS
- Evaluation of the effect of TIM-3 suppression by miR-498 and its effect on apoptosis and proliferation rate of HL-60 cell line
- (2018) Yaser Moghaddam et al. PATHOLOGY RESEARCH AND PRACTICE
- Tim-3 expression and its role in hepatocellular carcinoma
- (2018) Feifei Liu et al. Journal of Hematology & Oncology
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
- (2017) Guoying Zhou et al. GASTROENTEROLOGY
- High Tim-3 expression on AML blasts could enhance chemotherapy sensitivity
- (2017) Liangjing Xu et al. Oncotarget
- Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes
- (2017) Toshio Asayama et al. Oncotarget
- Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer
- (2017) Cinzia Solinas et al. Frontiers in Immunology
- The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
- (2017) Isabel Gonçalves Silva et al. EBioMedicine
- Targeted therapies for CLL: Practical issues with the changing treatment paradigm
- (2016) Nitin Jain et al. BLOOD REVIEWS
- Pediatric T-cell acute lymphoblastic leukemia
- (2016) Kristina Karrman et al. GENES CHROMOSOMES & CANCER
- Functional exhaustion of CD4+T cells induced by co-stimulatory signals from myeloid leukaemia cells
- (2016) Didem Ozkazanc et al. IMMUNOLOGY
- The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro
- (2016) Fatemeh Emamdoost et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Increased TIM3+CD8+T cells in Myelodysplastic Syndrome patients displayed less perforin and granzyme B secretion and higher CD95 expression
- (2016) Jinglian Tao et al. LEUKEMIA RESEARCH
- Adult Acute Lymphoblastic Leukemia
- (2016) Shilpa Paul et al. MAYO CLINIC PROCEEDINGS
- TIM-3 expression in lymphoma cells predicts chemoresistance in patients with adult T-cell leukemia/lymphoma
- (2016) Hasita Horlad et al. Oncology Letters
- The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro
- (2016) Fatemeh Emamdoost et al. Indian Journal of Hematology and Blood Transfusion
- Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1
- (2016) Noureldien H.E. Darwish et al. Oncotarget
- The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
- (2016) Isabel Gonçalves Silva et al. OncoImmunology
- A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
- (2015) Yoshikane Kikushige et al. Cell Stem Cell
- The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells
- (2015) Alexandr Prokhorov et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation
- (2015) Binh L. Phong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells
- (2015) Valentina Folgiero et al. Journal of Hematology & Oncology
- Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody
- (2015) Lidia Ciszak et al. TUMOR BIOLOGY
- PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation
- (2015) Y Kong et al. Blood Cancer Journal
- Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells
- (2015) Isabel Gonçalves Silva et al. Oncotarget
- Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion
- (2014) Robert L. Ferris et al. JOURNAL OF IMMUNOLOGY
- Tim-3 Directly Enhances CD8 T Cell Responses to Acute Listeria monocytogenes Infection
- (2014) J. V. Gorman et al. JOURNAL OF IMMUNOLOGY
- Elevated TIM3+ hematopoietic stem cells in untreated myelodysplastic syndrome displayed aberrant differentiation, overproliferation and decreased apoptosis
- (2014) Jing-lian Tao et al. LEUKEMIA RESEARCH
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- IDO2 in Immunomodulation and Autoimmune Disease
- (2014) George C. Prendergast et al. Frontiers in Immunology
- TIM3 expression by leukemic and non-leukemic myeloblasts
- (2013) Christine G. Roth et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study
- (2013) Namiko Okuyama et al. LEUKEMIA RESEARCH
- Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia
- (2013) Zhanshan Cha et al. TUMOR BIOLOGY
- Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions
- (2013) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- Epidemiology of Myelodysplastic Syndromes
- (2012) Xiaomei Ma AMERICAN JOURNAL OF MEDICINE
- Chronic Lymphocytic Leukemia
- (2012) Mohammed Shanshal et al. DM DISEASE-A-MONTH
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
- (2012) Manu Rangachari et al. NATURE MEDICINE
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
- (2011) Lukas Baitsch et al. JOURNAL OF CLINICAL INVESTIGATION
- Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
- (2011) J. Lee et al. MOLECULAR AND CELLULAR BIOLOGY
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Galectin-9 regulates T helper cell function independently of Tim-3
- (2010) E. W. Su et al. GLYCOBIOLOGY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
- (2010) Rosemarie H. DeKruyff et al. JOURNAL OF IMMUNOLOGY
- Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
- (2009) A Möricke et al. LEUKEMIA
- Is it important to decipher the heterogeneity of “normal karyotype AML”?
- (2008) Stephen D. Nimer BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now